{"id":"W4321372568","doi":"10.1093/neuonc/noad031","title":"Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Sidney Kimmel Comprehensive Cancer Center; National Institutes of Health; Hospital for Sick Children; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Centre de Recherche en Cancérologie de Marseille; Brain Tumour Charity; Murdoch Children's Research Institute; Children’s Hospital of Wisconsin Research Institute; Alder Hey Children's NHS Foundation Trust; Morgan Adams Foundation; Children's Hospital Colorado; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Clinical endpoint; Adverse effect; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001579148,0.0003922927,0.0007809394,0.0005233937,0.0001088608,0.00002328041,0.0001286333,0.0001633119,0.00006930465],"category_scores_gemma":[0.00008570742,0.0002543153,0.0000505609,0.00123626,0.0001778384,0.00007849053,0.0001323546,0.00026576,0.00006268968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002204401,"about_ca_system_score_gemma":0.0002983863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008885736,"about_ca_topic_score_gemma":0.0002908137,"domain_scores_codex":[0.9976141,0.0001620991,0.000448572,0.0007113049,0.0004019052,0.0006619449],"domain_scores_gemma":[0.9984866,0.0005483081,0.0002013131,0.0003559603,0.0001147663,0.0002930677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007067157,0.003003474,0.964438,0.000184973,0.0001676964,0.002980466,0.0004936504,0.0000492138,0.006544237,0.00001679473,0.003643587,0.0114108],"study_design_scores_gemma":[0.06011224,0.008599192,0.917834,0.00009588652,0.0006974478,0.0001610277,0.0001040996,0.0003050056,0.002754491,0.000007336611,0.008985202,0.000344048],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954735,0.0001608771,0.000003355487,0.002066852,0.0002678198,0.001507708,0.00004734523,0.0001861106,0.0002864014],"genre_scores_gemma":[0.9973016,0.001197946,0.0003543188,0.0005857955,0.0001034765,0.0002053264,0.0001085695,0.00008821462,0.00005477729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05304509,"threshold_uncertainty_score":0.9999909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02134899312938557,"score_gpt":0.2924929071080651,"score_spread":0.2711439139786795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}